Understanding immune responses to improve vaccines and treatments
NIH Tetramer Core Facility
This study is all about improving our understanding of how our immune system works, and it helps scientists create better vaccines and treatments for infections and immune-related diseases, which could eventually lead to new options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10667255 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of immune responses, particularly through the use of Major Histocompatibility Complex (MHC) tetramers. These specialized reagents are synthesized and distributed to researchers worldwide to aid in the development of vaccines and therapies for infectious and immune-mediated diseases. By providing essential resources and support, this initiative aims to facilitate advancements in public health and improve treatment outcomes for patients. Patients may benefit indirectly as new vaccines and therapies are developed based on the findings from this research.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by infectious diseases or immune-mediated disorders.
Not a fit: Patients with conditions unrelated to immune responses or infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and treatments for infectious diseases and immune disorders.
How similar studies have performed: Previous research utilizing MHC tetramers has shown promise in advancing our understanding of immune responses, indicating a potential for success in this approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.